ID   MHCC97-H CD44s shRNA
AC   CVCL_VU23
DR   cancercelllines; CVCL_VU23
DR   GEO; GSM940337
DR   GEO; GSM940338
DR   GEO; GSM940339
DR   Wikidata; Q95989435
RX   PubMed=25886575;
CC   Population: Chinese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; 1681; CD44.
CC   Sequence variation: Mutation; HGNC; 14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Transcriptome analysis by microarray.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4972 ! MHCC97-H
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=25886575; DOI=10.1186/s12885-015-1166-4;
RA   Dang H., Steinway S.N., Ding W., Rountree C.B.;
RT   "Induction of tumor initiation is dependent on CD44s in c-Met(+)
RT   hepatocellular carcinoma.";
RL   BMC Cancer 15:161.1-161.11(2015).
//